Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne
Xconomy
OCTOBER 23, 2017
Things have been moving quickly in recent weeks for the San Diego RNA drug developer Arcturus Therapeutics. In a statement last week, Arcturus said it would work with Janssen to develop and commercialize its proprietary technologies for developing nucleic acid-based drug products for the treatment of hepatitis B.
Let's personalize your content